FANAPT (ILOPERIDONA)
Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99303756
- Mark type
- Word mark
- Filed
- 25 Jul 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of manic or mixed episodes associated with bipolar I disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Dec 2025 — ASSIGNED TO EXAMINER
- 04 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Jul 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 25 Jul 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 25 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Jul 2025 — NEW APPLICATION ENTERED